Merkel cell carcinoma in collision with squamous cell carcinoma and basal cell carcinoma in a patient on ruxolitinib treatment for myeloproliferative neoplasm
JAAD Case Reports · 2024-03 · 45 · 98-101
DOI: 10.1016/j.jdcr.2024.01.024 ↗Kurz gefasst
Fallbericht in der Zeitschrift JAAD Case Reports, 2024-03. Verfasst von Viviana Barrera-Penagos und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratories, Fundación Santa Fe de Bogotá, Bogotá D.C., Colombia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Janus kinase inhibitors (JAK-I) have been gaining importance in the treatment of myeloproliferative neoplasms (MPNs), such as myelofibrosis and polycythemia vera.1 One of the most used JAK-I indicated for the treatment MPN is ruxolitinib, a potent oral selective inhibitor of JAK1 and JAK2.1 Its use has been shown to improve the quality of life of patients with MPN, reducing splenomegaly and symptom burden compared with the previous standard treatment.2,3 However, clinical trials that have evaluated the long-term effects of the use of ruxolitinib have found cases of newly diagnosed nonmelanoma skin cancer (NMSC) after 5 years of exposure among patients with myelofibrosis and polycythemia vera.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology and Laboratories, Fundación Santa Fe de Bogotá, Bogotá D.C., Colombia.
- Division of Head and Neck Surgery, Fundación Santa Fe de Bogotá, Bogotá D.C., Colombia.
- School of Medicine, Universidad de los Andes, Bogotá D.C., Colombia.
Zitieren
APA
Barrera-Penagos, V., Castellanos-Leguizamón, D., Hakim-Tawil, J. A., Santivañez, J. J., Rodríguez-Urrego, P. A., & Hiromi López-Takegami, J. C. (2024). Merkel cell carcinoma in collision with squamous cell carcinoma and basal cell carcinoma in a patient on ruxolitinib treatment for myeloproliferative neoplasm. JAAD Case Reports, 45, 98-101. https://doi.org/10.1016/j.jdcr.2024.01.024
Vancouver
Barrera-Penagos V, Castellanos-Leguizamón D, Hakim-Tawil JA, Santivañez JJ, Rodríguez-Urrego PA, Hiromi López-Takegami JC. Merkel cell carcinoma in collision with squamous cell carcinoma and basal cell carcinoma in a patient on ruxolitinib treatment for myeloproliferative neoplasm. JAAD Case Reports. 2024;45:98-101. doi:10.1016/j.jdcr.2024.01.024
BibTeX
@article{BarreraPenagos2024,
author = {Barrera-Penagos, Viviana and Castellanos-Leguizamón, Daniela and Hakim-Tawil, José Antonio and Santivañez, Juan José and Rodríguez-Urrego, Paula A and Hiromi López-Takegami, Juan Carlos},
title = {Merkel cell carcinoma in collision with squamous cell carcinoma and basal cell carcinoma in a patient on ruxolitinib treatment for myeloproliferative neoplasm},
journal = {JAAD Case Reports},
year = {2024},
volume = {45},
pages = {98--101},
doi = {10.1016/j.jdcr.2024.01.024}
}
EUVIMED